Literature DB >> 25554728

Reshaping the chromatin landscape after spinal cord injury.

Jamie K Wong1, Hongyan Zou2.   

Abstract

The pathophysiology underlying spinal cord injury is complex. Mechanistic understanding of the adaptive responses to injury is critical for targeted therapy aimed at reestablishing lost connections between proximal and distal neurons. After injury, cell-type specific gene transcription programs govern distinct cellular behaviors, and chromatin regulators play a central role in shaping the chromatin landscape to adjust transcriptional profiles in a context-dependent manner. In this review, we summarize recent progress on the pleiotropic roles of chromatin regulators in mediating the diverse adaptive behaviors of neurons and glial cells after spinal cord injury, and wherever possible, discuss the underlying mechanisms and genomic targets. We specifically draw attention to the perspective that takes into consideration the impact of epigenetic modulation on axon growth potential, together with its effect on wound-healing properties of glial cells. Epigenetic modulation of chromatin state represents an emerging therapeutic direction to promote neural repair and axon regeneration after spinal cord injury.

Entities:  

Keywords:  axon regeneration; chromatin; epigenetics; neural repair; spinal cord injury

Year:  2014        PMID: 25554728      PMCID: PMC4280023          DOI: 10.1007/s11515-014-1329-8

Source DB:  PubMed          Journal:  Front Biol (Beijing)        ISSN: 1674-7984


  83 in total

1.  Origin of new glial cells in intact and injured adult spinal cord.

Authors:  Fanie Barnabé-Heider; Christian Göritz; Hanna Sabelström; Hirohide Takebayashi; Frank W Pfrieger; Konstantinos Meletis; Jonas Frisén
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

2.  Injury-induced HDAC5 nuclear export is essential for axon regeneration.

Authors:  Yongcheol Cho; Roman Sloutsky; Kristen M Naegle; Valeria Cavalli
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

Review 3.  Can the immune system be harnessed to repair the CNS?

Authors:  Phillip G Popovich; Erin E Longbrake
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

4.  Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study.

Authors:  D Bartholdi; M E Schwab
Journal:  Eur J Neurosci       Date:  1997-07       Impact factor: 3.386

5.  HDAC6 is a target for protection and regeneration following injury in the nervous system.

Authors:  Mark A Rivieccio; Camille Brochier; Dianna E Willis; Breset A Walker; Melissa A D'Annibale; Kathryn McLaughlin; Ambreena Siddiq; Alan P Kozikowski; Samie R Jaffrey; Jeffery L Twiss; Rajiv R Ratan; Brett Langley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

Review 6.  Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection.

Authors:  Barbara Monti; Elisabetta Polazzi; Antonio Contestabile
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

7.  Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury.

Authors:  Ina B Wanner; Mark A Anderson; Bingbing Song; Jaclynn Levine; Ana Fernandez; Zachary Gray-Thompson; Yan Ao; Michael V Sofroniew
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

8.  Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats.

Authors:  J Xu; G Fan; S Chen; Y Wu; X M Xu; C Y Hsu
Journal:  Brain Res Mol Brain Res       Date:  1998-08-31

9.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

Authors:  Kevin D Beck; Hal X Nguyen; Manuel D Galvan; Desirée L Salazar; Trent M Woodruff; Aileen J Anderson
Journal:  Brain       Date:  2010-01-19       Impact factor: 13.501

10.  Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia.

Authors:  Wen-Hsin Lu; Chih-Yen Wang; Po-See Chen; Jing-Wen Wang; De-Maw Chuang; Chung-Shi Yang; Shun-Fen Tzeng
Journal:  J Neurosci Res       Date:  2013-02-13       Impact factor: 4.164

View more
  5 in total

1.  An Intrinsic Epigenetic Barrier for Functional Axon Regeneration.

Authors:  Yi-Lan Weng; Ran An; Jessica Cassin; Jessica Joseph; Ruifa Mi; Chen Wang; Chun Zhong; Seung-Gi Jin; Gerd P Pfeifer; Alfonso Bellacosa; Xinzhong Dong; Ahmet Hoke; Zhigang He; Hongjun Song; Guo-Li Ming
Journal:  Neuron       Date:  2017-04-19       Impact factor: 17.173

2.  Comprehensive mapping of 5-hydroxymethylcytosine epigenetic dynamics in axon regeneration.

Authors:  Yong-Hwee Eddie Loh; Andrew Koemeter-Cox; Mattéa J Finelli; Li Shen; Roland H Friedel; Hongyan Zou
Journal:  Epigenetics       Date:  2016-12-05       Impact factor: 4.528

3.  Epitranscriptomic m6A Regulation of Axon Regeneration in the Adult Mammalian Nervous System.

Authors:  Yi-Lan Weng; Xu Wang; Ran An; Jessica Cassin; Caroline Vissers; Yuanyuan Liu; Yajing Liu; Tianlei Xu; Xinyuan Wang; Samuel Zheng Hao Wong; Jessica Joseph; Louis C Dore; Qiang Dong; Wei Zheng; Peng Jin; Hao Wu; Bin Shen; Xiaoxi Zhuang; Chuan He; Kai Liu; Hongjun Song; Guo-Li Ming
Journal:  Neuron       Date:  2018-01-17       Impact factor: 17.173

4.  Protein deacetylases and axonal regeneration.

Authors:  Fanny Ng; Bor Luen Tang
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

5.  Glial fibrillary acidic protein levels are associated with global histone H4 acetylation after spinal cord injury in rats.

Authors:  Mayara Ferraz de Menezes; Fabrício Nicola; Ivy Reichert Vital da Silva; Adriana Vizuete; Viviane Rostirola Elsner; Léder Leal Xavier; Carlos Alberto Saraiva Gonçalves; Carlos Alexandre Netto; Régis Gemerasca Mestriner
Journal:  Neural Regen Res       Date:  2018-11       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.